about
Chemical Imaging of Platinum-Based Drugs and their MetabolitesHigh Throughput In Situ DDA Analysis of Neuropeptides by Coupling Novel Multiplex Mass Spectrometric Imaging (MSI) with Gas-Phase FractionationMALDI FTICR IMS of Intact Proteins: Using Mass Accuracy to Link Protein Images with Proteomics DataMALDI-TOF MS as a Novel Tool for the Estimation of Postmortem Interval in Liver Tissue Samples.High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples.MALDI mass spectrometric imaging meets "omics": recent advances in the fruitful marriage.An introduction to MS imaging in drug discovery and development.Exemplifying the Screening Power of Mass Spectrometry Imaging over Label-Based Technologies for Simultaneous Monitoring of Drug and Metabolite Distributions in Tissue Sections.Quantitative mass spectrometry imaging of small-molecule neurotransmitters in rat brain tissue sections using nanospray desorption electrospray ionization.Visualizing spatial distribution of alectinib in murine brain using quantitative mass spectrometry imagingHigh-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue.Maleic anhydride proton sponge as a novel MALDI matrix for the visualization of small molecules (<250 m/z) in brain tumors by routine MALDI ToF imaging mass spectrometry.Molecular imaging of small molecule drugs in animal tissues using laser desorption postionization mass spectrometry.High-throughput high-volume nuclear imaging for preclinical in vivo compound screening§Next-generation technologies for spatial proteomics: Integrating ultra-high speed MALDI-TOF and high mass resolution MALDI FTICR imaging mass spectrometry for protein analysis.Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging.Combination of MALDI-MSI and cassette dosing for evaluation of drug distribution in human skin explant.Mass spectrometry imaging for clinical research - latest developments, applications, and current limitations.Analysis of Chemotherapeutic Drug Delivery at the Single Cell Level Using 3D-MSI-TOF-SIMS.Signal preprocessing, multivariate analysis and software tools for MA(LDI)-TOF mass spectrometry imaging for biological applications.Visualization of metallodrugs in single cells by secondary ion mass spectrometry imaging.Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axisEvaluation of the heterogeneous tissue distribution of erlotinib in lung cancer using matrix-assisted laser desorption ionization mass spectrometry imaging.IR-MALDESI Mass Spectrometry Imaging at 50 Micron Spatial Resolution.A pneumatically assisted nanospray desorption electrospray ionization source for increased solvent versatility and enhanced metabolite detection from tissue.MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.Matrix-Assisted Laser Desorption/Ionisation Mass Spectrometry Imaging in the Study of Gastric Cancer: A Mini Review.Heterogeneous distribution of alectinib in neuroblastoma xenografts revealed by matrix-assisted laser desorption ionization mass spectrometry imaging: a pilot study.Correlating microscopy techniques and ToF-SIMS analysis of fully grown mammalian oocytes.Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging.Light-Dependent Changes in the Spatial Localization of Metabolites in (Coleus Henna) Visualized by Matrix-Free Atmospheric Pressure Electrospray Laser Desorption Ionization Mass Spectrometry ImagingMatrix-enhanced nanostructure initiator mass spectrometry (ME-NIMS) for small molecule detection and imagingBiological tissue sample preparation for time-of-flight secondary ion mass spectrometry (ToF–SIMS) imaging
P2860
Q28817949-4844497B-4A84-4DF6-85D3-E6BA35CB2D53Q28834511-5CE05EE0-7DC2-43B1-A091-E7E3FBDBA915Q30938681-DA58848E-D111-469E-8023-87F37574BFD6Q33884847-BDCE72AD-1A7B-40BC-8529-0BC277DA7EB2Q35628046-861DBDA8-B9EB-49AF-AAA3-0472999A7BD2Q35687880-92DA1832-FDBD-43F5-A01C-5D2EB78D142FQ35825043-2544F83C-C72F-4FA9-A557-705FA26D40D9Q35877759-3E991DF4-A066-4FEF-B82E-157B213D4D2DQ35917986-84154A9E-C464-461B-BFB2-28D3FE3C8C6FQ35973401-A04357E0-9002-437A-9637-9972DE7C5D6FQ36077253-601FE5F9-06E3-44FF-920E-EE7CEC30B0D0Q36078411-2C8C72BF-F623-417B-A8F6-3DA6A7AACFE1Q36308227-B70541E2-68E6-486D-9E1A-8930E23F97A5Q36340673-627C22F7-FE18-4007-9B31-AAE809A7E499Q37426939-C1342097-D610-4138-A857-5CE988C52459Q37522770-E5051175-03E4-48BD-A159-5F5B13B07B4CQ38688777-1D570642-3C28-4A6E-8E57-AA18EDA4DEC4Q38712870-A8FE666F-2913-4572-874B-03DF1362C5E6Q38735220-2097DD38-C435-4322-9B4A-97F4E72C6779Q39012950-226D124A-FF5B-46CC-A8E3-11903A52111EQ39309141-C1A8364A-0A51-4A23-A81B-D7DCD8EB2C03Q41124799-68AF5D7C-387E-4A3A-80CD-14A21C607F4AQ42282683-27D616C9-7798-4CA6-ABB6-326CEE693909Q44873975-F33B4C14-F4A7-48E9-9968-7E8C230416F1Q46318148-2940ADDD-D7B3-4EA8-9ACF-E0FE9D36A593Q47114407-14C9D43E-2721-43AF-92DC-D6C0B14B219EQ47212589-FD2E4716-52FD-4E6E-AA51-155D0DDAB9D7Q48193794-BA272C19-C040-40D1-9B28-C738AE02270CQ48551120-7C15F206-22BF-4037-8421-3B1783E56492Q54979887-3F1554AE-E140-4C84-8A20-86186583952EQ57073089-970970DE-64F2-4920-87DE-CE5744ACB5FFQ57434053-38CAC6B6-07C1-4083-A34B-2D567F145D72Q59133378-C46CDE34-A716-4FFC-AAC5-FE0AB4C4A3C4
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Mass spectrometry imaging in drug development.
@ast
Mass spectrometry imaging in drug development.
@en
type
label
Mass spectrometry imaging in drug development.
@ast
Mass spectrometry imaging in drug development.
@en
prefLabel
Mass spectrometry imaging in drug development.
@ast
Mass spectrometry imaging in drug development.
@en
P2093
P356
P1433
P1476
Mass spectrometry imaging in drug development.
@en
P2093
Anna Nilsson
Mohammadreza Shariatgorji
Per E Andrén
Peter J H Webborn
Richard J A Goodwin
Theodosia Vallianatou
P304
P356
10.1021/AC504734S
P407
P577
2015-01-14T00:00:00Z